Our recent LinkedIn poll suggests 90% believe pharma's agencies should be Code-trained. Listen to our 3 top tips about the why, what and how representing best practice for ALL agencies.

Rina & Jean chat about how the PMCPA ruled (Case AUTH/3662/6/22) for a case about dynamic content generated from sharing buttons. Can they move? Should they be certified? Or simply checked?

Aargh with no definition of a promotional claim in the ABPI Code AND a terrible definition for a promotional aid, is it any wonder we are confused? Rina & Jean suggest a clear solution (after a little bit of moaning). See our comments and please send yours by 29 Feb 24, link here).

Rina & Jean discuss the proposed change in the 2024 Code for signatories requiring validation. Our top tips? Start PLANNING now, list out TASKS and COMMENT on the changes (see our comments and please send yours by 29 Feb 24, link here).

Rina & Jean reflect on all the great discussion from the Code Clarity Conference and what comments could be made on the upcoming PMCPA consultation.

Deaghlan O'Hagan joins Rina to discuss the why, who and what of anon complaints, covering 3 pain points and potential solutions.

Complaints about "garbage" need to be specific! Jean covers Case AUTH/3696/10/22 and why SOBI were ruled not in breach.

Sick of long e-sales aids that contain too much info about clinical trials? Is this less or more of a compliance risk? Listen as we suggest practical solutions.

Rina & Jean discuss some myths (please let us know if you think of others). We will be putting these to Alex Fell (Director, PMCPA) at our Annual Conference.

Rina & Jean cover the recent ruling in Case AUTH/3701/10/22 (Astellas v Janssen) and discuss pharma providing nurse support, patient support programmes and inducements to individuals.